A drug with the SMILES CCN1CCN(C(=O)C(NS(=O)(=O)c2ccc3nc(C)sc3c2)C(C)C)CC1 has a human ether-à-go-go related gene (hERG) inhibition at 1uM of 3.529\%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_1uM__names__noun} of {herg_central_at_1uM#}{herg_central_at_1uM__units}.
CCN1CCN(C(=O)C(NS(=O)(=O)c2ccc3nc(C)sc3c2)C(C)C)CC1
CCN1CCN(C(=O)C(NS(=O)(=O)c2ccc3nc(C)sc3c2)C(C)C)CC1
[C][C][N][C][C][N][Branch2][Ring2][=Branch1][C][=Branch1][C][=O][C][Branch2][Ring1][=Branch2][N][S][=Branch1][C][=O][=Branch1][C][=O][C][=C][C][=C][N][=C][Branch1][C][C][S][C][Ring1][=Branch1][=C][Ring1][#Branch2][C][Branch1][C][C][C][C][C][Ring2][Ring1][#Branch2]
N-[1-(4-ethylpiperazin-1-yl)-3-methyl-1-oxobutan-2-yl]-2-methyl-1,3-benzothiazole-6-sulfonamide